Breast Imaging Reporting and Data System Category 3 Lesions Detected on Whole-Breast Screening Ultrasound
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Sang Yu | - |
dc.contributor.author | Ko, Eun Young | - |
dc.contributor.author | Han, Boo-Kyung | - |
dc.contributor.author | Shin, Jung Hee | - |
dc.contributor.author | Ko, Eun Sook | - |
dc.contributor.author | Hahn, Soo Yeon | - |
dc.date.available | 2020-02-28T00:44:40Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-09 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7956 | - |
dc.description.abstract | Purpose: This study assessed the incidence and cancer rate of probably benign lesions detected on bilateral whole-breast screening ultrasound (US), which corresponded to US Breast Imaging Reporting and Data System (BI-RADS) category 3, and evaluated the proper management of those lesions. Methods: This study was approved by the Institutional Review Board in our institution, which waived informed patient consent. We retrospectively reviewed US images of 1,666 patients who underwent bilateral whole-breast screening US as a supplemental screening test to negative screening mammography or screening US only. The incidence, clinical course, and cancer rate of screening US detected probably benign lesions corresponding to US BI-RADS category 3 were investigated, and the size and multiplicity of screening US-detected category 3 lesions were evaluated. Results: Probably benign lesions corresponding to US BI-RADS category 3 were detected in 689 of 1,666 patients (41.4%) who underwent screening US. Among them, 653 had follow-up US images for at least 24 months, and among these 653, 190 (29.1%) had multiple bilateral category 3 lesion. Moreover, 539 of 1,666 patients (32.4%) had lesions 1 cm in size and 114 of 1,666 (6.8%) had lesions >1 cm (median, 0.82 cm; range, 0.34.2 cm). Four of the 653 patients (0.6%) showed suspicious interval changes and were categorized into BI-RADS category 4. Biopsy analysis confirmed only one lesion as invasive ductal carcinoma at the 6-month follow-up; another lesion was an intraductal papilloma and the remaining two were fibroadenomas. Overall cancer rate of the screening US-detected BI-RADS category 3 lesions was 0.2%. Conclusion: The incidence of category 3 lesions detected on screening US only was very high, but the cancer rate was very low. Therefore, in an average-risk population, routine screening US is preferable over short-term followup for BI-RADS category 3 lesions detected on whole-breast screening US. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN BREAST CANCER SOC | - |
dc.relation.isPartOf | JOURNAL OF BREAST CANCER | - |
dc.subject | DENSE BREASTS | - |
dc.subject | CANCER INCIDENCE | - |
dc.subject | ELEVATED RISK | - |
dc.subject | MAMMOGRAPHY | - |
dc.subject | WOMEN | - |
dc.subject | US | - |
dc.subject | SONOGRAPHY | - |
dc.subject | ULTRASONOGRAPHY | - |
dc.subject | PERFORMANCE | - |
dc.subject | ACCURACY | - |
dc.title | Breast Imaging Reporting and Data System Category 3 Lesions Detected on Whole-Breast Screening Ultrasound | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000384386800010 | - |
dc.identifier.doi | 10.4048/jbc.2016.19.3.301 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BREAST CANCER, v.19, no.3, pp.301 - 307 | - |
dc.identifier.kciid | ART002148850 | - |
dc.identifier.scopusid | 2-s2.0-84992064868 | - |
dc.citation.endPage | 307 | - |
dc.citation.startPage | 301 | - |
dc.citation.title | JOURNAL OF BREAST CANCER | - |
dc.citation.volume | 19 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Nam, Sang Yu | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Breast | - |
dc.subject.keywordAuthor | Mass screening | - |
dc.subject.keywordAuthor | Ultrasonography | - |
dc.subject.keywordPlus | DENSE BREASTS | - |
dc.subject.keywordPlus | CANCER INCIDENCE | - |
dc.subject.keywordPlus | ELEVATED RISK | - |
dc.subject.keywordPlus | MAMMOGRAPHY | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | US | - |
dc.subject.keywordPlus | SONOGRAPHY | - |
dc.subject.keywordPlus | ULTRASONOGRAPHY | - |
dc.subject.keywordPlus | PERFORMANCE | - |
dc.subject.keywordPlus | ACCURACY | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.